Hepatitis B treatment
Tune Therapeutics Secures $175M in Series B Funding to Advance Epigenome Editing Programs
Epigenome editing, Tune Therapeutics, Series B funding, Hepatitis B treatment, Gene therapy, Biotech investment
Actionable Insights Powered by AI
Epigenome editing, Tune Therapeutics, Series B funding, Hepatitis B treatment, Gene therapy, Biotech investment